J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...

Goldman Sachs analyst Rajan Sharma maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...

IDEAYA Biosciences is a promising biotech company targeting genetic vulnerabilities in cancer cells with synthetic lethality.

The pioneering DNA testing firm has been struggling to stay afloat financially despite ambitious ventures to provide health ...

Kyverna Therapeutics, Inc. (Kyverna), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell ...

CHELMSFORD, MA / ACCESSWIRE / September 16, 2024 / (NASDAQ:HHS), a global leader in customer experience for over 100 years, today announced a leadership transition within its sales organization. Jason ...

Women in England with a specific type of endometrial cancer will be able to access an immunotherapy for the first time, after NICE backed use of ... The success of clinical trials hinges on ...

CHELMSFORD, MA / ACCESSWIRE / September 16, 2024 / Harte Hanks, Inc. (NASDAQ:HHS), a global leader in customer experience for over 100 years, today announced a leadership transition within its sales ...

Lexington ranks in the top 10 among mid-size U.S. cities for attracting Generation Z graduates to live and begin their work ...

The first patient has been treated with an implantable bioelectronic device developed by Galvani Therapeutics, set up by GlaxoSmithKline ... jury is out on that. The success of clinical trials ...

Learn more about A+ Investor here! Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection. To decide if GSK plc (ADR) ...

Ginkgo Bioworks , which is building the leading platform for cell programming and biosecurity, proudly announces the launch ...